Roche Diagnostics

Selected news for the company - Roche Diagnostics, collected since 10/2017. This company shares news with Siemens, Thermo Fisher, Abbott Laboratories, Thermo Fisher Scientific, COVID-19 and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Biosensors Market 2022 Growth Opportunities & Forecasts to 2027 themarketpublicist.com ... that have a fast response time has significantly grown, as has target population pool.Essentially, firms operating in the biosensors market are developing new products and solutions. For example, in 2020, major market player, Roche Diagnostics , in partnership with SD Biosensor Inc., announced the launch of a rapid antigen test to quickly screen and detect people suspected of being exposed to the coronavirus.Meanwhile, in 2022, University of Washington researchers ...
1/12/2022 Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care Yahoo News ... careBasel, 12 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics ’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter ...
1/12/2022 Roche Launches Cobas Pulse System In Select Countries - Quick Facts | Nasdaq Nasdaq RTTNews) - Roche (RHHBY) announced the launch of the cobas pulse system in select countries accepting the CE Mark. The device marks Roche Diagnostics ' newest generation of connected point of care solutions for professional blood glucose management. The cobas pulse system's portability and Android-based interface make using it as simple as a smartphone, the company noted.Following first commercial availability under CE Mark in select markets, the company plans to ...
1/12/2022 Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care - Scientific Technology News scientifictechnologynews.com ... Basel, 12 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics ’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter ...
1/12/2022 Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care roche.com ... careBasel, 12 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics ’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter ...
1/12/2022 Roche launches the cobas® pulse system, an industry first Globe Newswire ... careBasel, 12 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics ’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter ...
1/12/2022 Codagenix Welcomes Bruce Taillon as Executive Vice President of Animal Health PR Newswire ... of new and innovative animal health solutions. Previously, he was Global Head, Business & Product Development, at Enzo Life Sciences and Director of Technology and Director of Healthcare Business Development at 454 Life Sciences, a Roche Diagnostics company. After graduating with a B.S. in Biology from the University of South Carolina , Taillon earned his Ph.D. in Biological Sciences from Carnegie Mellon University . He also completed post-doctoral training through the National ...
1/12/2022 Codagenix Welcomes Bruce Taillon as Executive Vice President of Animal Health tncontentexchange.com ... of new and innovative animal health solutions. Previously, he was Global Head, Business & Product Development, at Enzo Life Sciences and Director of Technology and Director of Healthcare Business Development at 454 Life Sciences, a Roche Diagnostics company. After graduating with a B.S. in Biology from the University of South Carolina, Taillon earned his Ph.D. in Biological Sciences from Carnegie Mellon University. He also completed post-doctoral training through the National ...
1/12/2022 Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care itbusinessnet.com ... Basel, 12 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics ’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter ...
1/12/2022 JPM 2022: Roche launches smart, hand-held glucose meter for the hospital bedside FierceBiotech ... levels during a patient's hospital stay.“Frontline health workers are under increasing pressure to not only accurately diagnose patients, but also make appropriate decisions on all aspects of disease management and patient care,” Roche Diagnostics CEO Thomas Schinecker, Ph.D., said in a statement.The hand-held cobas pulse includes an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results, all in ...
1/11/2022 4 thoughts on Lancets Market Overview | Growth Drivers | Restraints | Opportunities, and Trends | Insights by Geography | Competitive Landscape Wordpress.com ... developing countries are restricting the growth of this market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487Leading Key Players and Analysis:Prominent players in the lancets market are Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).Roche Diagnostics (Switzerland) was the leading player in ...
1/11/2022 Roche Unveils Cobas Infinity Edge, Digital Ecosystem For Point Of Care Professionals | Nasdaq Nasdaq RTTNews) - Roche (RHHBY) said that it has introduced cobas infinity edge, a secure and encrypted cloud-based platform for the integration and management of point of care data, available for use in clinical settings globally.Roche Diagnostics plans to offer the new digital platform in other markets globally throughout 2022 and 2023.Cobas infinity edge is designed as an open platform, allowing healthcare professionals to easily access and adopt third ...
1/11/2022 FDA Grants Emergency Use Authorization For Roche's At-Home COVID-19 Test thehealthcaretechnologyreport.com Multinational healthcare company Roche has been given an Emergency Use Authorization by the FDA for its at-home rapid COVID-19 test. The test, soon to be available over-the-counter at pharmacies and select retailers in the U.S., uses a home-testing-friendly nasal swab sample procedure that produces results in roughly 20 minutes for all known variants of COVID-19, including the recent, quickly spreading Omicron.Roche Diagnostics ...
1/11/2022 Freenome Nets $290M Investment from Roche | 360Dx 360dx.com ... screening and data-driven medical insights will help deliver personalized healthcare. This investment will be an important step to advance early cancer screening, and we look forward to joining Freenome in this journey," added Roche Diagnostics CEO Thomas Schinecker ...
1/11/2022 Freenome Nets $290M Investment from Roche | Genomeweb genomeweb.com ... screening and data-driven medical insights will help deliver personalized healthcare. This investment will be an important step to advance early cancer screening, and we look forward to joining Freenome in this journey," added Roche Diagnostics CEO Thomas Schinecker ...
1/7/2022 Portable Medical Electronic Devices-markedsstørrelse og prognose 2022 etter andel, vekstfaktorer, konkurrentprofiler, krav, nylige trender, industridynamikk og regional analyse norskposten.com Portable Medical Electronic Devices-markedet 2021 Blomstrende strategi før og etter COVID-19, etter bedriftsstrategianalyse, landskap, type, applikasjon og ledende 20 land dekker og analyserer potensialet til den globale Portable Medical Electronic Devices-industrien. Rapporten gir også en grundig analyse av kjernearbeidstrender og fremtidige markedsutviklingsutsikter, bestemmende faktorer og moderering, profiler av store, markedsbarrierer, muligheter og utfordringer. Denne Portable Medical Electronic Devices-markedsrapporten hjelper på beslutningsnivå for å utforme markedsføringsprosedyrer ...
1/7/2022 Global Hepatitis Test Solution/Diagnosis Market Size, Share and Analysis to Expand At 3.9% CAGR Through 2028 themarketpublicist.com ... 2021 and is forecast to a readjusted size of USD 3971.9 million by 2028 with a CAGR of 3.9% during review period.Global key companies of Hepatitis Test Solution/Diagnosis Market include Abbott Laboratories, Roche Diagnostics , Bio-Rad, Siemens Healthineers, and Diasorin, etc. In terms of revenue, the global top four players hold a share over % in 2021.Request a sample Report of Hepatitis Test Solution/Diagnosis Market at: https ...
1/6/2022 Global Sexually Transmitted Diseases (STDs) Testing Devices Market 2019- Roche Diagnostics, BioMerieux, Hologic, Inc., Becton Dickinson & Company ccguardian.com ... by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, and Japan.Key companies profiled in Sexually Transmitted Diseases (STDs) Testing Devices Market report are Roche Diagnostics, BioMerieux, Hologic, Inc., Becton Dickinson & Company, Cepheid, Inc., Danaher Corporation, Affymetrix, Inc., Alere, Inc., Abbott Laboratories, DiaSorin and more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross ...
1/6/2022 MoPH sets maximum price for Covid-19 rapid test kits gulf-times.com ... price for Covid-19 rapid test kits in Qatar.According to the circular, the maximum price for the supplies and products of rapid test kits of Covid-19 has been set at QR35 for Roche Diagnostics GmbH devices and QR25 for devices of other manufacturers.There are no comments.LEAVE A COMMENT Your email address will not be published. Required fields are marked Doha Metro at 60% capacity from Saturday ...
1/5/2022 The crucial role that diagnostics play in the healthcare ecosystem MSN The crucial role that diagnostics play in the healthcare ecosystem Gulfbusiness.com 5 days ago Varun Godinho © Motivate Publishing Guido Sander, general manager of Roche Diagnostics Middle EastIt’s difficult to understate the importance of in vitro diagnostics (IVD) in the healthcare ecosystem.Reportedly, 70 per cent of all healthcare decisions are based on the outcome of the sound diagnostic results. Yet, diagnostics account for only 2 per cent of ...